Top Markets
#1 Cortex Cortex +173.86%
#2 GEKKO GEKKO +51.79%
#3 Audiera Audiera +22.10%
#4 Pons Pons +17.28%
#5 ADO Protocol ADO Protocol +17.26%
#6 TENDIES TENDIES +16.07%
#7 Ontology Gas Ontology Gas +14.07%
#8 o1.exchange o1.exchange +13.03%
#9 Helium Helium +12.67%
#10 Siren Siren +12.60%
Coin of the day
Cortex Cortex
Settings
Language
ENGLISH
Currency
USD
Theme
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Rank in Stocks #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Share Price
$59.98
Last synced: 2024-12-13
Market Cap
$1.22B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Longboard Pharmaceuticals, Inc. (LBPH)

Category

Healthcare
Earnings for Longboard Pharmaceuticals, Inc. (LBPH)
Earnings in Sep 2024 TTM: $-76.34M
According to Longboard Pharmaceuticals, Inc. latest financial reports the company's current earnings are $-76.34M. In 2022 the company made an earning of $-43.95M, a decrease compared to its 2021 earnings that were of $-27.80M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Longboard Pharmaceuticals, Inc. from 2020 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-76.34M 40.28%
2023 $-54.42M 23.84%
2022 $-43.95M 58.09%
2021 $-27.80M 93.03%
2020 $-14.40M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -7,009.38%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -2,655.08%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B 5,160.66%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B 3,943.54%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH